Keyphrases
Ischemic Cardiomyopathy
100%
Implantable Defibrillator
100%
New York Heart Association
100%
Arrhythmic Burden
100%
New York Heart Association Class
50%
Implantable Cardioverter-defibrillator Shock
50%
Primary Prevention
33%
Implantable Cardioverter Defibrillator Registry
33%
Israeli
16%
Multivariate Model
16%
High Risk
16%
Consecutive Patients
16%
Mortality Rate
16%
High Mortality Rate
16%
Confidence Interval
16%
Hazard Ratio
16%
Left Ventricular Dysfunction
16%
Cumulative Incidence
16%
Clinical Benefit
16%
Ventricular Arrhythmia
16%
Cardioverter-defibrillator Implantation
16%
Incremental Benefits
16%
Competing Risks
16%
Symptomatic Patients
16%
Device Therapy
16%
Heart Failure Symptoms
16%
Implantable Cardioverter-defibrillator Therapy
16%
New York Heart Association Functional Class
16%
Competing Risk of Death
16%
Nursing and Health Professions
Ischemic Cardiomyopathy
100%
Implantable Cardioverter Defibrillator
100%
New York Heart Association Class
44%
Mortality Rate
22%
Primary Prevention
22%
Symptom
11%
Confidence Interval
11%
Hazard Ratio
11%
Heart Failure
11%
Cohort Analysis
11%
Heart Left Ventricle Failure
11%
Device Therapy
11%
Heart Ventricle Arrhythmia
11%
Medicine and Dentistry
Ischemic Cardiomyopathy
100%
Implantable Automatic Defibrillator
100%
New York Heart Association Class
44%
Mortality Rate
22%
Primary Prevention
22%
Symptom
11%
Hazard Ratio
11%
Cohort Analysis
11%
Heart Failure
11%
Heart Left Ventricle Failure
11%
Cumulative Incidence
11%
Heart Ventricle Arrhythmia
11%
Device Therapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ischemic Cardiomyopathy
100%
Mortality Rate
50%
Symptom
25%
Cohort Study
25%
Heart Failure
25%
Heart Left Ventricle Failure
25%
Heart Ventricle Arrhythmia
25%